AzTrials
AzTrials

Cerebral PalsyPhase 2NCT01028833

Effects of Power Mobility on Young Children With Severe Motor Impairments

A Phase 2 study testing Power mobility in people with Cerebral Palsy and Arthrogryposis, run by University of Oklahoma at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose this study is to determine the effects of power mobility on the development and function of young children of young children whose severe physical disabilities limit their exploratory behaviors and may unnecessarily restrict their cognitive, communication, and social-emotional development. Read more about this study

Who is it for?
Ages 14 to 30 months
What is being tested?
Power mobility
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteUnited States
Study dates
Nov 2008to Dec 2012
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 30 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Must be between 14- and 30-months of age
  • Must have clinical diagnosis of a motor impairment that prevents functional independent mobility
  • Must have adequate vision and hearing to use power mobility device safely
  • Must have cognitive abilities equivalent to a 12-month level or alertness and interest in the environment that suggests a trial of power mobility is warranted

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Department of Rehabilitation Sciences, Lee Mitchener Tolbert Center for Develompental Disabilities

    Oklahoma City, Oklahoma, 73117

Other trials in United States

About this study

Official title: Effects of Power Mobility on the Development and Function of Young Children With Severe Motor Impairments

The purpose this study is to determine the effects of power mobility on the development and function of young children of young children whose severe physical disabilities limit their exploratory behaviors and may unnecessarily restrict their cognitive, communication, and social-emotional development.

Being tested
Power mobility
Keywords
power wheelchairs, power mobility, young children
Medical subject headings
Cerebral Palsy, Arthrogryposis, Muscular Atrophy, Spinal, Musculoskeletal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Power mobilityOther

    Project staff will use structured power mobility training program to teach the children to use the power mobility devices. Project staff will schedule 1-hour sessions with each family 3 times per week for the first month of the project and will decrease in the following manner as the child becomes proficient and develops basic wheelchair maneuvering skills: two one-hour session per week for 4 weeks; one one-hour session per week for 4 weeks; two one-hour sessions per month for 4 weeks; one one-hour session per month for the remainder of the study.

Study groups in NCT01028833
Study groupRoleWhat they receive
Power mobilityExperimentalIntervention included provision of power wheelchair and power mobility training program. Project staff will use structured power mobility training program to teach the children to use the power mobility devices. Project staff will schedule 1-hour sessions with each family 3 times per week for the first month of the project and will decrease in the following manner as the child becomes proficient and develops basic wheelchair maneuvering skills: two one-hour session per week for 4 weeks; one one-hour session per week for 4 weeks; two one-hour sessions per month for 4 weeks; one one-hour session per month for the remainder of the study.
Receives: Other: Power mobility
ControlNo interventionChildren in the control group will not receive any additional intervention, but will continue to receive the early intervention or other services they were receiving prior to enrollment in this study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Merrill-Palmer-Revised

    Measured: Entry, 6-months, and 12-months

  2. Pediatric Evaluation of Disability Inventory

    Measured: Entry, 6-months, 12-months

Secondary outcomes (7)
  1. Child Health Status

    Measured: Entry

  2. Two-position object permanence test

    Measured: Entry, 6 months, 12 months

  3. Nonspeech Test

    Measured: Entry, 6 month, 12 months

  4. Home Observation Measure of the Environment

    Measured: Entry, 6 months, 12 months

  5. Parenting Stress Inventory

    Measured: Entry, 6 months, 12 months

  6. Center for Epidemiologic Studies Depression Scale (CES-D)

    Measured: Entry, 6 months, 12 months

  7. Hollingshead Scale

    Measured: Entry

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2009 (estimated)
  2. Study startNov 2008
  3. Primary completionDec 2012
  4. Study completionDec 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01028833
Sponsor's protocol ID
2480
Status last verified
Jan 2016
First submitted
7 Dec 2009
Last updated
14 Jan 2016
Results posted
No
Data monitoring committee
No

Publications

  • Mockler SR, McEwen IR, Jones MA. Retrospective Analysis of Predictors of Proficient Power Mobility in Young Children With Severe Motor Impairments. Arch Phys Med Rehabil. 2017 Oct;98(10):2034-2041. doi: 10.1016/j.apmr.2017.05.028. Epub 2017 Jul 5.

    PubMed 28688787

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Power mobility in people with Cerebral Palsy and Arthrogryposis, run by University of Oklahoma at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Merrill-Palmer-Revised (time frame: Entry, 6-months, and 12-months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01028833, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2016; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in